文献速递病毒性肝炎艾滋病与性传播感染

乙型肝炎/人类免疫缺陷病毒共感染中脂肪肝疾病的演变及其与脂蛋白和临床结局的关系

Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection.
PubMed 文献 · Clin Infect Dis · 2022-01-01

BACKGROUND: Fatty liver disease (FLD) and hepatitis B virus (HBV) infection occur commonly in human immunodeficiency virus (HIV). FLD resolution is associated with improvement in lipoproteins in HIV-uninfected patients.…

要点

  • 共感染队列中基线脂肪肝病患病率为30%,短期随访无显著变化。
  • 脂肪肝病持续存在者基线LDL-C、LDL-P、apoB较高,提示心血管风险可能增加。
  • 脂肪肝病状态个体变化与脂蛋白变化之间未发现独立关联。

核心结论

  • 在HBV/HIV共感染队列中,相对短时间随访内脂肪肝病患病率无显著变化。
  • 基线致动脉粥样硬化脂质在持续脂肪变性或脂肪性肝炎者中最高,提示该组心血管风险可能增加。
  • 未观察到脂肪肝病状态个体变化与脂蛋白水平变化之间的独立关系。

主要发现

  • 随访期间脂肪肝病恶化或改善与未变化者相比,未发现与脂质/脂蛋白变化的关联。

临床怎么用

  • 对HBV/HIV共感染者应关注脂肪肝病,尤其持续脂肪变性或脂肪性肝炎者,可能需评估心血管风险。
  • 短期随访中脂肪肝病状态变化不直接反映脂蛋白变化,脂质管理应独立评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fatty liver disease (FLD) and hepatitis B virus (HBV) infection occur commonly in human immunodeficiency virus (HIV). FLD resolution is associated with improvement in lipoproteins in HIV-uninfected patients. We evaluated changes in FLD in an HBV/HIV-coinfected cohort. METHODS: One hundred eight HBV/HIV-coinfected adults with baseline liver biopsies were followed every 24 weeks (median, 166 weeks) and 60 had follow-up biopsies. Baseline FLD categories (none, ≥5% steatosis, steatohepatitis), their change, and relationships with clinical and lipid/lipoprotein parameters were explored using multivariable modeling. RESULTS: Median age was 50 years, and 93% were male. At baseline 30% had FLD. With control for lipid-lowering medications and body mass index, low-density lipoprotein (LDL) cholesterol (LDL-C), LDL particle concentration (LDL-P), and apolipoprotein B (apoB) decreased and adiponectin increased over time (all P < .05); On follow-up (vs baseline), there was no significant difference in FLD category (P = .85); 60% remained without FLD, 17% had unchanged, 12% worsening, and 12% improved FLD. Baseline low-density lipoproteins (LDL-C, LDL-P, small LDL-P) and apoB appeared highest in those with unchanged FLD status (all P < .05). No associations between changes in FLD across follow-up (worsening/improvement vs unchanged) and lipid/lipoproteins changes were identified. CONCLUSIONS: In this cohort, there was no significant change in FLD prevalence over a relatively short timeframe. Baseline atherogenic lipids appeared highest in those with persistent steatosis or steatohepatitis, suggesting potentially increased cardiovascular risk in this group, but an independent relationship between individual-level change in FLD status and lipid/lipoprotein levels across follow-up was not observed.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Khalili M, King WC, Kleiner DE, et al. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. Clin Infect Dis. 2022. PMID: 34698347. doi:10.1093/cid/ciab764

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。